These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome. Kuzmina Z; Krenn K; Petkov V; Körmöczi U; Weigl R; Rottal A; Kalhs P; Mitterbauer M; Ponhold L; Dekan G; Greinix HT; Pickl WF Blood; 2013 Mar; 121(10):1886-95. PubMed ID: 23303823 [TBL] [Abstract][Full Text] [Related]
6. CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease. Greinix HT; Kuzmina Z; Weigl R; Körmoczi U; Rottal A; Wolff D; Kralj M; Kalhs P; Mitterbauer M; Rabitsch W; Edinger M; Holler E; Pickl WF Biol Blood Marrow Transplant; 2015 Feb; 21(2):250-8. PubMed ID: 25460358 [TBL] [Abstract][Full Text] [Related]
7. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease. Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF Front Immunol; 2019; 10():334. PubMed ID: 30894856 [TBL] [Abstract][Full Text] [Related]
8. A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation. Chirumbolo G; Dicataldo M; Barone M; Storci G; De Matteis S; Laprovitera N; Sinigaglia B; Barbato F; Maffini E; Cavo M; Bonifazi F; Arpinati M Transplant Cell Ther; 2023 May; 29(5):302.e1-302.e8. PubMed ID: 36796518 [TBL] [Abstract][Full Text] [Related]
9. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation. Inagaki J; Moritake H; Nishikawa T; Hyakuna N; Okada M; Suenobu S; Nagai K; Honda Y; Shimomura M; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J Biol Blood Marrow Transplant; 2015 Nov; 21(11):1973-80. PubMed ID: 26234723 [TBL] [Abstract][Full Text] [Related]
10. National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen. Saillard C; Crocchiolo R; Furst S; El-Cheikh J; Castagna L; Signori A; Oudin C; Faucher C; Lemarie C; Chabannon C; Granata A; Blaise D Leuk Lymphoma; 2014 May; 55(5):1106-12. PubMed ID: 23822538 [TBL] [Abstract][Full Text] [Related]
11. Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review. Milosevic E; Babic A; Iovino L; Markovic M; Grce M; Greinix H Front Immunol; 2022; 13():1033263. PubMed ID: 36389657 [TBL] [Abstract][Full Text] [Related]
12. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation. Minculescu L; Marquart HV; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Haastrup E; Fischer-Nielsen A; Reekie J; Sengelov H Front Immunol; 2019; 10():1997. PubMed ID: 31507601 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency. Scarselli A; Di Cesare S; Capponi C; Cascioli S; Romiti ML; Di Matteo G; Simonetti A; Palma P; Finocchi A; Lucarelli B; Pinto RM; Rana I; Palumbo G; Caniglia M; Rossi P; Carsetti R; Cancrini C; Aiuti A J Clin Immunol; 2015 May; 35(4):373-83. PubMed ID: 25875698 [TBL] [Abstract][Full Text] [Related]
14. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution. Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643 [TBL] [Abstract][Full Text] [Related]
15. Posttransplantation cyclophosphamide mediates effective reconstitution of memory B cells after allogeneic hematopoietic cell transplantation. Hayashi T; Nakashima Y; Takeda S; Nishimoto M; Okamura H; Takakuwa T; Kuno M; Makuuchi Y; Ido K; Sakatoku K; Horiuchi M; Koh H; Nakamae M; Hino M; Nakamae H Eur J Haematol; 2024 Nov; 113(5):651-663. PubMed ID: 39072897 [TBL] [Abstract][Full Text] [Related]
16. [Correlation between immune reconstitution and chronic graft-versus-host disease after unrelated cord blood transplantation and sibling peripheral blood stem cell transplantation]. Wang J; Pan TZ; Huang PP; Sun ZM; Zhu HP Zhonghua Xue Ye Xue Za Zhi; 2021 Jun; 42(6):466-473. PubMed ID: 34384152 [No Abstract] [Full Text] [Related]
17. Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset. Bohmann EM; Fehn U; Holler B; Weber D; Holler E; Herr W; Hoffmann P; Edinger M; Wolff D Ann Hematol; 2017 Feb; 96(2):299-310. PubMed ID: 27942862 [TBL] [Abstract][Full Text] [Related]
18. Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria. Cuvelier GDE; Nemecek ER; Wahlstrom JT; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Flower A; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savaşan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; West LJ; Pan B; Al Hamarneh YN; Halevy A; Schultz KR Blood; 2019 Jul; 134(3):304-316. PubMed ID: 31043425 [TBL] [Abstract][Full Text] [Related]
19. Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease. Khoder A; Alsuliman A; Basar R; Sobieski C; Kondo K; Alousi AM; Szydlo R; Muftuoglu M; Shaim H; Apperley JF; Gokdemir E; Cooper N; Mehta RS; Marin D; Champlin R; Shpall E; Rezvani K Front Immunol; 2017; 8():1937. PubMed ID: 29375566 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria. Kuzmina Z; Gounden V; Curtis L; Avila D; Rnp TT; Baruffaldi J; Cowen EW; Naik HB; Hasni SA; Mays JW; Mitchell S; Baird K; Steinberg SM; Pavletic SZ Am J Hematol; 2015 Feb; 90(2):114-9. PubMed ID: 25363867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]